Venous retinal branch occlusion

Known as: branch retinal vein occlusion, retinal vein branch occlusion, branch vein retinal occlusion 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Retinal Vein Occlusion

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study.
PURPOSE Assess 12-month efficacy and safety of intraocular injections of 0.3 mg or 0.5 mg ranibizumab in patients with macular… (More)
Is this relevant?
Highly Cited
2010
Highly Cited
2010
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
OBJECTIVE To evaluate the safety and efficacy of dexamethasone intravitreal implant (DEX implant; OZURDEX, Allergan, Inc., Irvine… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 4
  • table 2
Is this relevant?
Review
2008
Review
2008
Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities
In branch retinal vein occlusion (BRVO), abnormal arteriovenous crossing with vein compression, degenerative changes of the… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study.
OBJECTIVES To describe the 15-year incidence of retinal vein occlusion (central retinal vein occlusion and branch retinal vein… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Intravitreal Avastin for macular oedema secondary to retinal vein occlusion: a prospective study.
OBJECTIVE To evaluate efficacy and safety of intravitreal bevacizumab (Avastin) in eyes with macular oedema secondary to central… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion.
PURPOSE To investigate clinical, anatomic, and electrophysiologic response after single intravitreal injection of bevacizumab for… (More)
  • table 1
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.
PURPOSE To determine whether correlations between vascular endothelial growth factor (VEGF) or interleukin-6 (IL-6) contribute to… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.
PURPOSE To describe the prevalence and the 5-year incidence of retinal central and branch vein occlusion and associated risk… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Incidence of various types of retinal vein occlusion and their recurrence and demographic characteristics.
We analyzed data on 1,108 patients (1,229 eyes) with various types of retinal vein occlusion. Retinal vein occlusion was… (More)
Is this relevant?
Highly Cited
1992
Highly Cited
1992
Ischemic macular edema. Recognition and favorable natural history in branch vein occlusion.
Eyes with macular edema caused by retinal branch vein occlusion underwent masked evaluation of fluorescein angiography to… (More)
Is this relevant?